Mitsuo Matsuda
Overview
Explore the profile of Mitsuo Matsuda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
786
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hanazawa K, Shiomi H, Morimoto T, Ando K, Furukawa Y, Tada T, et al.
Circ J
. 2025 Jan;
89(3):364-372.
PMID: 39864826
Background: Fatal arrhythmic events (FAEs), such as sudden cardiac death (SCD) and fatal ventricular arrhythmias, are a devastating complication in patients with coronary artery disease (CAD). Therefore, in this study...
2.
Kanenawa K, Yamaji K, Morimoto T, Yamamoto K, Domei T, Hyodo M, et al.
J Cardiol
. 2024 Jun;
84(4):300-310.
PMID: 38871119
Background: The impact of very low baseline levels of low-density lipoprotein cholesterol (LDL-C) on patients with coronary artery disease remains unclear. Method: We enrolled 39,439 patients of the pooled population...
3.
Obayashi Y, Shiomi H, Morimoto T, Miyake M, Inoko M, Nishikawa R, et al.
Am J Cardiol
. 2023 Jul;
203:384-393.
PMID: 37517134
It is important to clarify the precise impact of mitral regurgitation (MR) on long-term outcomes in acute myocardial infarction (AMI) patients who underwent percutaneous coronary intervention (PCI). In the Coronary...
4.
Kaneda K, Shiomi H, Abe M, Morimoto T, Yamamoto K, Obayashi Y, et al.
Am J Cardiol
. 2023 Jul;
202:58-66.
PMID: 37421731
Post-contrast acute kidney injury (PC-AKI) is a common complication after percutaneous coronary intervention (PCI). However, it is unclear whether or not the effects of PC-AKI on long-term clinical outcomes were...
5.
Matsuda S, Kato T, Morimoto T, Taniguchi T, Minamino-Muta E, Matsuda M, et al.
J Cardiol
. 2022 Aug;
81(2):144-153.
PMID: 36028354
Background: There has been no previous report evaluating the long impact of atrial fibrillation (AF) on the clinical outcomes stratified by the initial management [conservative or aortic valve replacement (AVR)]...
6.
Obayashi Y, Shiomi H, Morimoto T, Tamaki Y, Inoko M, Nishikawa R, et al.
Am J Cardiol
. 2022 Aug;
181:9-17.
PMID: 35973833
The clinical significance of the CHADS score remains unclear in patients with coronary artery disease (CAD) without atrial fibrillation (AF). Therefore, the purpose of this study was to evaluate the...
7.
Hiramori S, Yamashita Y, Morimoto T, Kadota K, Takase T, Kim K, et al.
J Cardiol
. 2022 Jul;
80(5):487-494.
PMID: 35882615
Background: Vitamin K antagonist (VKA) remains an essential option for venous thromboembolism (VTE), although direct oral anticoagulants have become available. However, there is a paucity of data on the optimal...
8.
Yamamoto K, Natsuaki M, Morimoto T, Shiomi H, Takeji Y, Yamaji K, et al.
Am J Cardiol
. 2021 Dec;
164:34-43.
PMID: 34852931
Recently, one observational study showed that patients with ST-segment elevation myocardial infarction (STEMI) without standard cardiovascular risk factors were associated with increased mortality compared with patients with risk factors. This...
9.
Yamamoto K, Natsuaki M, Morimoto T, Shiomi H, Yoshikawa Y, Tazaki J, et al.
Am J Cardiol
. 2021 Oct;
162:13-23.
PMID: 34706818
There is a scarcity of data on ischemic and bleeding events in patients who experienced major bleeding after percutaneous coronary intervention (PCI). Moreover, there also is a shortage of data...
10.
Obayashi Y, Shiomi H, Morimoto T, Tamaki Y, Inoko M, Yamamoto K, et al.
J Am Heart Assoc
. 2021 Sep;
10(18):e021417.
PMID: 34533047
Background It remains controversial whether long-term clinical impact of newly diagnosed atrial fibrillation (AF) in the acute phase of acute myocardial infarction (AMI) is different from that of prior AF...